AU2002234799A1 - Gene expression profiling of primary breast carcinomas using arrays of candidate genes - Google Patents

Gene expression profiling of primary breast carcinomas using arrays of candidate genes

Info

Publication number
AU2002234799A1
AU2002234799A1 AU2002234799A AU3479902A AU2002234799A1 AU 2002234799 A1 AU2002234799 A1 AU 2002234799A1 AU 2002234799 A AU2002234799 A AU 2002234799A AU 3479902 A AU3479902 A AU 3479902A AU 2002234799 A1 AU2002234799 A1 AU 2002234799A1
Authority
AU
Australia
Prior art keywords
arrays
gene expression
expression profiling
candidate genes
primary breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002234799A
Inventor
Francois Bertucci
Daniel Birnbaum
Vincent Fert
Remi Houlgatte
Catherine Nguyen
Patrice Viens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPSOGEN
Original Assignee
IPSOGEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPSOGEN filed Critical IPSOGEN
Publication of AU2002234799A1 publication Critical patent/AU2002234799A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2002234799A 2000-12-08 2001-12-07 Gene expression profiling of primary breast carcinomas using arrays of candidate genes Abandoned AU2002234799A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25409000P 2000-12-08 2000-12-08
US60/254,090 2000-12-08
US10/007,926 2001-12-07
US10/007,926 US20030143539A1 (en) 2000-12-08 2001-12-07 Gene expression profiling of primary breast carcinomas using arrays of candidate genes
PCT/IB2001/002811 WO2002046467A2 (en) 2000-12-08 2001-12-07 Gene expression profiling of primary breast carcinomas using arrays of candidate genes

Publications (1)

Publication Number Publication Date
AU2002234799A1 true AU2002234799A1 (en) 2002-06-18

Family

ID=26677525

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002234799A Abandoned AU2002234799A1 (en) 2000-12-08 2001-12-07 Gene expression profiling of primary breast carcinomas using arrays of candidate genes

Country Status (6)

Country Link
US (3) US20030143539A1 (en)
EP (1) EP1353947A2 (en)
JP (2) JP2004537261A (en)
AU (1) AU2002234799A1 (en)
CA (1) CA2430981A1 (en)
WO (1) WO2002046467A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820447B2 (en) 2000-12-22 2010-10-26 Sagres Discovery Inc. Compositions and methods for cancer
US7645441B2 (en) * 2000-12-22 2010-01-12 Sagres Discovery Inc. Compositions and methods in cancer associated with altered expression of PRLR
WO2002099421A2 (en) * 2001-05-18 2002-12-12 Thomas Jefferson University Specific microarrays for breast cancer screening
EP2258872B1 (en) * 2002-03-13 2013-08-14 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
EP1361433A3 (en) * 2002-04-09 2005-02-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
DE10229391A1 (en) * 2002-06-29 2004-01-29 Forschungszentrum Karlsruhe Gmbh Biochip, useful for identifying metastatizing tumors and assessing metastatic potential, carries cDNA copies of genes with metastasis-specific expression and of control genes
EP1382969A1 (en) 2002-07-17 2004-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diagnosis and prevention of cancer cell invasion
AU2003275173A1 (en) * 2002-09-25 2004-04-19 Board Of Regents, The University Of Texas System Endogenous granzyme b in human non-hematopoietic cells
WO2004046386A1 (en) 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
AU2012206980B2 (en) * 2003-01-15 2015-02-05 Genomic Health, Inc. Gene expression markers for breast cancer prognosis
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
CA2516553C (en) 2003-02-20 2013-04-16 Genomic Health, Inc. Use of intronic rna to measure gene expression
US20040229225A1 (en) * 2003-05-16 2004-11-18 Jose Remacle Determination of a general three-dimensional status of a cell by multiple gene expression analysis on micro-arrays
US20050064455A1 (en) * 2003-05-28 2005-03-24 Baker Joffre B. Gene expression markers for predicting response to chemotherapy
EP3170906B1 (en) 2003-06-24 2018-08-22 Genomic Health, Inc. Prediction of likelihood of cancer recurrence
DK1644858T3 (en) 2003-07-10 2018-01-22 Genomic Health Inc Functional clothing with at least one outer layer and inner membrane.
EP1892306A3 (en) * 2003-10-06 2008-06-11 Bayer HealthCare AG Methods and kits for investigating cancer
EP1538218A1 (en) * 2003-12-04 2005-06-08 Erasmus University Medical Center Rotterdam Method to diagnose or screen for inflammatory diseases
WO2005064019A2 (en) 2003-12-23 2005-07-14 Genomic Health, Inc. Universal amplification of fragmented rna
WO2005080570A1 (en) 2004-02-24 2005-09-01 Mitsubishi Rayon Co., Ltd. Gene relating to estimation of postoperative prognosis for breast cancer
JP2005270093A (en) * 2004-02-24 2005-10-06 Nippon Medical School Gene participating in estimating postoperative prognosis of breast cancer
JP5813908B2 (en) 2004-04-09 2015-11-17 ジェノミック ヘルス， インコーポレイテッド Gene expression markers to predict response to chemotherapeutic agents
US7587279B2 (en) 2004-07-06 2009-09-08 Genomic Health Method for quantitative PCR data analysis system (QDAS)
US20060063184A1 (en) * 2004-09-09 2006-03-23 Felix Carolyn A Compositions and methods for the detection of DNA topoisomerase II complexes with DNA
EP1836629B1 (en) 2004-11-05 2020-03-04 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
JP4939425B2 (en) 2004-11-05 2012-05-23 ジェノミック ヘルス， インコーポレイテッド Molecular indicators of prognosis and prediction of treatment response in breast cancer
US20070072175A1 (en) * 2005-05-13 2007-03-29 Biogen Idec Ma Inc. Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
BRPI0616139A2 (en) 2005-09-22 2011-06-07 China Synthetic Rubber Corp method for assessing the risk of distant metastasis, nucleic acid microstructure useful in determining the risk of distant metastasis and collection in medium or kit
EP2177910A1 (en) * 2005-11-10 2010-04-21 Aurelium Biopharma Inc. Tissue diagnostics for breast cancer
AR059432A1 (en) 2006-02-10 2008-04-09 Genentech Inc ANTI-FGF19 ANTIBODIES AND METHODS USING THESE
JP5167155B2 (en) 2006-03-09 2013-03-21 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム Compositions and methods related to profiling of multiple cell lines based on peptide bonds
EP2142670A1 (en) * 2007-04-05 2010-01-13 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of breast cancer
CA2693852C (en) 2007-08-03 2016-11-29 Genentech, Inc. Humanized anti-fgf19 antagonists and methods using same
US20110244459A1 (en) * 2008-12-10 2011-10-06 Ipsogen Methods for identifying erbb2 alteration in tumors
CA2749947A1 (en) * 2009-01-30 2010-08-05 Bayer Healthcare Llc Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition
EP3974832A1 (en) 2011-10-06 2022-03-30 Aveo Pharmaceuticals, Inc. Predicting tumor response to anti-erbb3 antibodies
US9575115B2 (en) 2012-10-11 2017-02-21 Globalfoundries Inc. Methodology of grading reliability and performance of chips across wafer
US9169509B2 (en) 2013-01-15 2015-10-27 Board Of Regents, The University Of Texas System Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity
AU2016238253B2 (en) 2015-03-25 2022-06-16 The General Hospital Corporation Digital analysis of circulating tumor cells in blood samples
WO2018081625A2 (en) 2016-10-27 2018-05-03 The General Hospital Corporation Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
JP5213202B2 (en) * 1998-10-28 2013-06-19 バイシス・インコーポレーテツド Detection and use of cell arrays and markers of genetic disorders

Also Published As

Publication number Publication date
EP1353947A2 (en) 2003-10-22
JP2008178411A (en) 2008-08-07
CA2430981A1 (en) 2002-06-13
US20110086765A1 (en) 2011-04-14
WO2002046467A2 (en) 2002-06-13
JP4388983B2 (en) 2009-12-24
US20030143539A1 (en) 2003-07-31
US20130079234A1 (en) 2013-03-28
JP2004537261A (en) 2004-12-16
WO2002046467A3 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
AU2002234799A1 (en) Gene expression profiling of primary breast carcinomas using arrays of candidate genes
AU2002362454A1 (en) Regulated breast cancer genes
AU2001286643A1 (en) Gene discovery using microarrays
AU2002360769A1 (en) Breast cancer expression profiling
AU2002345089A1 (en) Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
WO2003018621A8 (en) Genes
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
AU8005598A (en) New uses for compounds which reduce (c-jun) gene expression
DE59913101D1 (en) GENES OF THE 1-DESOXY D-XYLULOSE BIOSYNTHESIS PATH
AU2001251069A1 (en) Gene profiling arrays
AU2001269472A1 (en) Fungal cell wall synthesis gene
AU2002214576A1 (en) Genes related to development of refractory prostate cancer
IL153651A0 (en) Fungal cell wall synthesis gene
AU7408301A (en) Novel target genes for diseases of the heart
AU2002360345A1 (en) Prostate cancer genes
AU2001227903A1 (en) Everninomicin biosynthetic genes
AU7709300A (en) Drug discovery using gene expression profiling
AU2003212826A1 (en) Cancer genes
AU2003285583A1 (en) Oligonucleotide guided analysis of gene expression
GB9910413D0 (en) Novel promoter of gene expression
AU2003282709A1 (en) Gene expression profiling of bladder cancer
AU2003282564A8 (en) Gene profiling of single or multiple cells
AU2001252634A1 (en) Myocardial cell proliferation-associated genes
AU2001278042A1 (en) Daz genes
AU4137501A (en) Finding homologs of known genes